Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares are soaring Wednesday. The price move was marked by unusually high volume. What To Know: Bluejay stock has been in decline since early August. The month was marked by negative catalysts such as the company's dismal second-quarter earnings report and the announcement of a $1.59 million registered direct offering of 216,000 shares at $7.365 per share. Shares fell over 135% since the beginning of August from the stock's three-month high. However, Bluejay stock spiked in price Wednesday on abnormally high volume. According to data from Benzinga Pro, the stock experienced above-average trading
What's Going On With Bluejay Diagnostics Stock Today?
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.